key: cord-0945452-0bpvvm5h
authors: Lourda, M.; Dzidic, M.; Hertwig, L.; Bergsten, H.; Palma Medina, L. M.; Kvedaraite, E.; Muvva, J. R.; Gorin, J.-B.; Cornillet, M.; Emgard, J.; Moll, K.; Garcia, M.; Maleki, K. T.; Klingstrom, J.; Michaelsson, J.; Flodstrom-Tullberg, M.; Brighenti, S.; Buggert, M.; Mjosberg, J.; Malmberg, K.-J.; Sandberg, J. K.; Henter, J.-I.; Folkesson, E.; Gredmark-Russ, S.; Sonnerborg, A.; Eriksson, L. I.; Rooyackers, O.; Aleman, S.; Stralin, K.; Ljunggren, H.-G.; Bjorkstrom, N. K.; Svensson, M.; Ponzetta, A.; Norrby-Teglund, A.; Chambers, B. J.; Group, Karolinska KIK COVID-19 Study
title: High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19
date: 2021-01-31
journal: nan
DOI: 10.1101/2021.01.27.21250591
sha: 8fa0584829b030fd4fd01fde9a24f48ab6beed5b
doc_id: 945452
cord_uid: 0bpvvm5h

Since the outset of the COVID-19 pandemic, increasing evidence suggests that the innate immune responses play an important role in the disease development. A dysregulated inflammatory state has been proposed as key driver of clinical complications in COVID-19, with a potential detrimental role of granulocytes. However, a comprehensive phenotypic description of circulating granulocytes in SARS-CoV-2-infected patients is lacking. In this study, we used high-dimensional flow cytometry for granulocyte immunophenotyping in peripheral blood collected from COVID-19 patients during acute and convalescent phases. Severe COVID-19 was associated with increased levels of both mature and immature neutrophils, and decreased counts of eosinophils and basophils. Distinct immunotypes were evident in COVID-19 patients, with altered expression of several receptors involved in activation, adhesion and migration of granulocytes (e.g. CD62L, CD11a/b, CD69, CD63, CXCR4). Paired sampling revealed recovery and phenotypic restoration of the granulocytic signature in the convalescent phase. The identified granulocyte immunotypes correlated with distinct sets of soluble inflammatory markers supporting pathophysiologic relevance. Furthermore, clinical features, including multi-organ dysfunction and respiratory function, could be predicted using combined laboratory measurements and immunophenotyping. This study provides a comprehensive granulocyte characterization in COVID-19 and reveals specific immunotypes with potential predictive value for key clinical features associated with COVID-19.

Caused by the novel coronavirus SARS-CoV-2, the current COVID-19 pandemic poses an 76 unprecedented threat to the global health systems, with over 2 million confirmed deaths 77 reported worldwide in January 2021 (https://www.who.int/emergencies/diseases/novel-78 coronavirus-2019). About 80% of COVID-19 patients present with a mild or moderate disease 79 course, while 15-20% develop severe complications (1, 2), including respiratory failure, 80 coagulation abnormalities and life-threatening acute respiratory distress syndrome (ARDS). 81

A dysregulated inflammatory state has been proposed as a key driver of clinical complications 82 of and has been associated with increased mortality (4). High levels of several 83 pro-inflammatory mediators (e.g. Interleukin-1β (IL-1β), IL-6, Tumor necrosis factor ⍺ 84 (TNF⍺) and CXCL8) are detected early after viral infection (5), and the resolution of this 85 inflammatory response seems impaired in patients with severe disease progression (5, 6). Many 86 of these pro-inflammatory cytokines are associated with granulocyte activation and recruitment 87 (7), and it has been reported that an increased neutrophil-to-lymphocyte ratio (NLR) in 88 peripheral blood can be used as a prognostic marker of higher disease severity in patients, similar to SARS-CoV-1 and MERS (8-10). 90

The cellular components of the polymorphonuclear granulocyte family -neutrophils, 91 eosinophils and basophils -arise from a common myeloid progenitor in humans (11) and 92 represent the very first line of defense against invading microbes. The role of granulocytes in 93 viral infection has mostly been confined to neutrophils (12, 13), though eosinophils and 94 basophils have been implicated in the host response to viruses as well (14, 15) . In 95 an increased neutrophil abundance in circulation is mirrored by a substantial enrichment of 96 granulocytes in the inflamed lung (16, 17) . Several reports highlighted the presence of 97 immature neutrophils in blood of 19) , implying a marked emergency 98 granulopoiesis occurring in the bone marrow. The presence of immature neutrophil populations 99 8 The analysis of absolute leukocyte counts in COVID-19 patients highlighted relevant 144 alterations in the granulocyte compartment in peripheral blood. In particular, neutrophils were 145 significantly increased in patients with severe disease course, while eosinophils and basophils 146 were decreased in COVID-19 patients when compared to non-infected healthy controls ( Figure  147 1D). A similar trend was observed in the relative frequencies of granulocyte subsets over total 148 leukocytes. A higher proportion of neutrophils in patients with moderate and severe respectively) was associated with the reduction of the 150 eosinophil and basophil fractions (up to 3 and 7.5-fold, respectively, Figure 1E ). The ratios of 151 neutrophils over eosinophils or basophils increased in both patient groups, while no difference 152 in the eosinophil to basophil ratios was observed between controls and patients (Supplemental 153 Figure 1A ). In line with previous reports (29), we found that severe COVID-19 was associated 154 with higher neutrophil-to-lymphocyte and neutrophil-to-T cell ratios, as determined by 155 absolute cell count ( Figure 1F , Supplemental Figure 1B ). We observed an opposite trend for 156 basophils, which was associated with disease severity, while we did not detect any significant 157 alteration in the eosinophil to lymphocyte or eosinophil to T cell ratios ( Figure 1F , 158 Supplemental Figure 1B) . 159

This set of data highlights that the granulocyte expansion observed during acute SARS-CoV-160 2 infection is dominated by neutrophils and is coupled to the reduction of the physiological 161 levels of circulating eosinophils and basophils. 162 163 Severe COVID-19 is characterized by the emergence of immature neutrophils in peripheral 164 blood 165

Neutrophils have been shown to display a high degree of phenotypical heterogeneity, which 166 has important implications on their function in several pathological contexts (30). Different 167 neutrophil maturation states are associated with major phenotypic differences, e.g. CD16 168 upregulation during development (23, 30) . In COVID-19 patients, particularly in those with 169 severe disease, we observed a robust enrichment of a neutrophil subset characterized by low 170 expression of CD16 suggesting that these were immature CD16 dim neutrophils (Figure 2A) . 171 A significant increase in absolute numbers was detected for both CD16 bright and CD16 dim 172 neutrophil subsets in COVID-19 patients, which positively correlated with disease severity 173 ( Figure 2B ). In addition, a significant increase in the relative fraction of CD16 dim neutrophils 174 was detected, indicating an overall expansion of immature neutrophils in COVID-19 patients 175 ( Figure 2C) . 176

In order to analyze the phenotypic traits of the neutrophil subsets identified above in an 177 unsupervised way, 30,000 events in the neutrophil gate from each study participant were 178 concatenated and then down-sampled to 0.5 million cells. By integrating the expression of 20 179 phenotypic markers in the UMAP analysis, we observed only modest differences comparing 180 neutrophils from healthy controls and COVID-19 patients, within the UMAP space ( Figure  181 2D). In addition, the CD16 bright and CD16 dim neutrophil subsets from controls and COVID-19 182 patients clustered separately from each other ( Figure 2E ), indicating substantial phenotypic 183 differences, which did not depend on the disease state. 184

Next, the expression of markers related to neutrophil development, migration and activation 185 was analyzed. The mature CD16 bright neutrophil subset was characterized by higher expression 186 of CD177, CD11b, CXCR1, CXCR2 and CD62L compared to the CD16 dim population. On the 187 other hand, CD16 dim neutrophils were characterized by higher levels of CD66b, LOX-1 and 188 CD24, which are associated to early stages of neutrophil development (31), confirming the 189 immature phenotype of this subset (Figures 2F-G, Supplemental Figures 2A-B) . 190 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 31, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 We also observed significant upregulation of CD66b, CD177, CD11b, CXCR4, CD147 (the 191 receptor that binds the spike protein of SARS-CoV-2) and CD63 in mature neutrophils from 192 COVID-19 patients compared to healthy controls, as well as significant downregulation of 193 CXCR2 ( Figure 2G , Supplemental Figure 2A ). No differences in the expression of markers 194 related to either co-stimulatory or inhibitory functions, such as HLA-DR, between healthy controls and COVID-19 patients within either neutrophil subset were detected 196 ( Figure 2G , Supplemental Figures 2A-B) . 197

While the presented analysis showed several phenotypic differences between healthy controls 198 and COVID-19 patients, we were unable to detect prominent alterations between the moderate 199 and severe patients for any of the neutrophil subsets analyzed ( Figure To investigate further whether specific neutrophil phenotypes were associated with disease 210 progression or severity, unsupervised phenograph clustering was performed on neutrophils 211 derived from all study participants ( Figure 3A ). In total, 27 clusters were identified with a 212 varying prevalence in the three study groups ( Figure 3B ). Hierarchical clustering based on 213 marker expression was sufficient to group clusters more abundant in moderate patients (i.e. 214 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 31, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 clusters 16, 22 and 27) ( Figure 3C ). Specifically, these clusters belonged to the CD16 bright 215 subset and displayed higher expression levels of CD11b, CD177 and CD66b. On the other 216 hand, clusters that were enriched in severe COVID-19 encompassed the immature CD16 dim 217 population and displayed a more heterogeneous phenotype ( Figure 3C ). In particular, clusters 218 18, 19 and 23, which were more enriched in severe patients, showed lower levels of several 219 activation markers including CD66b, CD11a and CD11b (Supplemental Figure 3A) . 220

Correlation of cluster frequencies in each patient with the concentration of 253 serum/plasma 221 factors (Supplemental Table 4 ) followed by hierarchical clustering highlighted specific 222 correlation patterns associated with trends in cluster enrichment within specific disease groups 223 ( Figure 3D ). In particular, clusters 16, 22 and 27, which were enriched in moderate COVID-224 19, displayed a positive correlation with several molecules of type 1 response (CXCL9, 225 CXCL10 and IL-15), anti-viral response (interferon regulatory factor 9 (IRF9), IL-12p70 and 226 interferon-ɣ (IFNɣ)) and adaptive immunity (B-cell activating factor (BAFF) and IL-2) ( Figure  227 3D). In addition, key molecules involved in eosinophil/basophil homeostasis and recruitment 228 (IL-5, CCL3 and stem cell factor (SCF)) were also positively correlated with these clusters. 229

Within the clusters associated with severe patients, several members of the coagulation cascade 230 (Factor VII, VIII and IX) and molecules associated with neutrophil maturation (i.e. 231 granulocyte-colony stimulating factor (G-CSF) and myeloperoxidase (MPO)) were positively 232 correlated ( Figure 3D ). Shared patterns within cluster groups (e.g. 22, 27 and 5, 23) were also 233 observed when separately analyzing correlations in moderate and severe COVID-19 234 (Supplemental Figure 3B and Supplemental Table 5 ), suggesting that the degree of disease 235 severity could influence relationships between specific neutrophil immunotypes and soluble 236 factors. 237 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 31, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 In summary, the phenograph-guided in-depth dissection of the neutrophil subset composition 238 allowed us to identify selected immunotypes associated with high circulating levels of 239 prototypical molecules of type-1 related anti-viral immune response. Figure 4A ). Phenotypic analysis showed differences between 250 healthy controls and COVID-19 patients, but also between patients with moderate and severe 251 COVID-19 for some of the parameters analyzed. Patients with moderate COVID-19 expressed 252 significantly higher levels of CD66b, CD11b, CD11a and CD24 compared to patients with 253 severe COVID-19 ( Figure 4C , Supplemental Figure 4B ). Notably within the severe group, the 254 deceased patients had the highest CD69 expression ( Figure 4C ). PCA analysis recapitulated 255 these differences, highlighting CD193, CD66b, CD11a, CD24, CXCR4 and CD62L as the 256 mostly affected parameters in eosinophils from COVID-19 patients ( Figure 4D ). 257

We observed that patients with COVID-19 also had a significantly increased frequency of 258 CD69 + eosinophils ( Figures 4E-F) . Indeed, despite the strong eosinopenia ( Figure 1D ), the 259 absolute counts of CD69 + eosinophils were not significantly altered in COVID-19 patients 260 ( Figure 4F ). CD69 + eosinophils displayed significantly higher expression of CD66b, CD147, 261 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 31, 2021. ; https://doi.org/10.1101/2021.01.27.21250591 doi: medRxiv preprint UMAP analyses revealed distinctive clusters in the healthy controls and COVID-19 patients, 286

suggesting alterations in basophil phenotype during the disease ( Figure 5A ). Specifically, 287 clusters associated with COVID-19 had higher expression of markers important for the 288 activation and recruitment of basophils, including CD11b, CD63, and CXCR4 ( Figure 5B ; 289 Supplemental Figure 5A ). Specific upregulation of CD62L, CD147 and CD177 were observed 290 on basophils from moderate COVID-19 patients ( Figure 5C , Supplemental Figure 5B ). On the 291 other hand, PD-L1 expression was reduced in all patients compared to healthy controls. The 292 differences in marker expression on basophils between healthy controls and COVID-19 293 patients were further confirmed by PCA, with CXCR4, CD62L, CD193 and PD-L1 among the 294 most contributing parameters driving the separation ( Figure 5D ). We further examined the 295 correlation of basophils with soluble factors ( Figure 5E , Supplemental Figure 5D -E). The 296 basophil frequency was negatively correlated with soluble DDX58, and with the transcription 297 factors amphiregulin (AREG), FOSB and Zinc finger and BTB domain-containing protein 16 298 (ZBTB16). Similar to eosinophils, basophil frequency was also negatively correlated with 299 CCL7. In contrast, CCL22, CCL28 and Fms-related tyrosine kinase 3 ligand (Flt3L) were 300 positively correlated to basophil frequency, particularly in COVID-19 patients with moderate 301 disease ( Figure 5E , Supplemental Figure 5E ). Other soluble factors that were also positively 302 associated with basophil frequency were CD83 and tumor necrosis factor-related apoptosis-303 inducing ligand (TRAIL). In summary, the data show that basophils are depleted in COVID-304 19 patients, a pattern associated with disease severity, and that circulating basophils from 305 patients display an activated phenotype. 306 307 Eosinophil activation and neutrophil maturation contribute to predictive models of Sequential 308

Organ Failure Assessment (SOFA) score and respiratory function 309 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 31, 2021. ; https://doi.org/10.1101/2021.01.27.21250591 doi: medRxiv preprint Our well-defined patient cohort allowed us to compare in detail the phenotypic alterations in 310 granulocyte subsets in relation to severity of COVID-19 (Supplemental Table 1 ). In order to 311 elucidate the underlying relationships between immune traits and relevant clinical parameters 312 registered during hospitalization, we performed multivariate linear regression. The models 313 were based on a comprehensive data set including surface marker expression levels, absolute 314 numbers, frequencies of granulocyte subsets, available clinical information and laboratory 315 measurements. The final set of variables used in the predictive models were selected based on 316 their correlation with the tested clinical outcomes and their relevance in the specific predictive 317 models ( Figure 6A ). 318

The analysis revealed that the levels of CD11a expression on eosinophils contributed to the 319 linear model for prediction of SOFA score for patients included in our study (Adj. R 2 =0.74, 320 p=3.8x10 -6 , Figure 6B ). Notably, the relevance of CD11a expression on eosinophils was higher 321 in predicting the SOFA score (explaining around 50% of the model) than the levels of two 322 laboratory parameters CRP and creatinine ( Figure 6C ). 323

We also developed models for prediction of respiratory function including PaO2/FiO2 (P/F) 324 ratio at baseline and maximum oxygen need during hospitalization. The linear model for P/F 325 ratio prediction (Adj. R 2 =0.60, p=1.9x10 -4 , Figure 6D ) included contributions of CD69 326 expression on CD16 dim neutrophils, of CD66b on eosinophils and of CRP. The linear model 327 for maximum level of oxygen administration encompassed absolute numbers of mature 328 neutrophils, CD66b expression on eosinophils and ferritin levels (Adj. R 2 =0.74, p=3.9x10 -6 , 329 Figure 6F ). Notably, both models revealed a correlation between CD66b expression on 330 eosinophils and degree of respiratory failure during COVID-19. Moreover, the combined effect 331 of the immune parameters in both models was dominant, contributing to almost 80% of each 332 model ( Figures 6C, 6E and 6G). Correction for relevant parameters (e.g. age, BMI, sex, co-333 morbidities) did not significantly alter any of the linear models or the contribution of the 334 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 31, 2021. ; https://doi.org/10.1101/2021.01.27.21250591 doi: medRxiv preprint immune cell populations to them, further strengthening the link between granulocyte activation 335 and clinical outcome (Supplemental Table 6 ). In summary, by applying a supervised machine-336 learning method we identified eosinophil activation and mature neutrophil counts to be strongly 337 correlated to SOFA score and maximum oxygen need. These immunological signatures, 338 together with other known laboratory markers, but not alone (Supplemental Figure 6 ), were 339 sufficient to create predictive models. 340

The phenotype of granulocytes is partly restored in patients who have recovered from COVID-342

To determine whether the phenotypical alterations observed within the granulocyte 344 compartment during acute COVID-19 were recovered after viral clearance, whole blood 345 samples were collected from the same moderate (n=8) or severe (n=7) patients approximately 346 four months (median=136 days, range=89-153 days) after hospital discharge ( Figure 7A PCA highlighted that convalescent patients were markedly more similar to healthy controls 355 than to acute patients ( Figure 7D ). In particular, CD69 and CD193 expression on eosinophils, 356 as well as CD147 expression on neutrophils and eosinophils, and basophil counts were among 357 the variables contributing to the observed clustering (Figures 7E-F, Supplemental Figure 7B ). 358 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 31, 2021. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 31, 2021. The release of immature neutrophils in circulation has been observed in previous studies 394 investigating a variety of viral infections, including HIV, dengue and SARS- 19, and is strictly associated with emergency granulopoiesis. Recent studies included CD63 396 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 31, 2021. ; https://doi.org/10.1101/2021.01.27.21250591 doi: medRxiv preprint mRNA levels in an immature pro/pre-neutrophil signature (31), which was found significantly 397 enriched in . In this regard, we found a robust CD63 upregulation on 398 CD16 dim neutrophils and a further increased expression in COVID-19 patients. Both moderate 399 and severe COVID-19 patients were characterized by the progressive expansion of CD16 dim 400 neutrophils, which also expressed lower levels of CD177, CD11b and CD62L and higher levels 401 of CD66b and LOX-1, a phenotype compatible with neutrophil immaturity (31). 402

Our in-depth phenograph-guided analysis of the neutrophil compartment revealed the 403 enrichment of activated neutrophil immunotypes in moderate COVID-19 patients, associated 404 with higher circulating levels of molecules involved in the IFN-mediated anti-viral response 405 (i.e. IRF9, IL-12b, IFNɣ). Neutrophils are known to be highly responsive to type I IFN in 406 different contexts (39, 40) and recent studies described the existence of an IFN-responsive, 407 developmentally distinct, neutrophil subset (41). Intriguingly, we observed a positive 408 correlation between type 1 inflammatory mediators (e.g. IFNɣ and CXCL10) and eosinophil 409 activation, suggesting that, particularly in moderately affected patients, part of the granulocyte 410 compartment could be actively participating in the efficient viral clearance, similarly to what 411 occurs upon influenza infection (42, 43) . Interestingly, CD62L expression on eosinophils can 412 be triggered by IFNɣ, and CD62L-expressing eosinophils have been suggested to contribute to 413 dysregulated inflammation and ARDS in acute 44) . 414

Eosinophils have been reported to express receptors that allow the recognition and 415 orchestration of anti-viral responses to respiratory viruses (43, 45, 46) . Eosinophil-associated 416 lung pathology has been reported in other viral infections and in SARS-CoV-1 vaccination 417 studies (summarized in (47)). On the other hand, the role of human basophils in viral infections 418 is poorly understood and mainly focused on basophil response to HIV (48, 49) . CXCR4 is one 419 of the most highly expressed basophil receptors in COVID-19 patients in our cohort and might 420 be implicated in basophil trans-endothelial migration (49). CD63 expression on basophils can 421 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 31, 2021. Combination of eosinopenia with elevated CRP could effectively triage suspected patients with 440 COVID-19 from other patients with fever (52). A relevant finding emerging from our study is 441 that selected granulocytic phenotypical traits could, in concert with other known laboratory 442 markers such as CRP or creatinine, predict to a significant extent, key clinical outcomes, 443 including respiratory functionality and SOFA score. Although this finding needs to be taken 444 with caution considering the limited size of our patient cohort, we provide the proof-of-445 principle that the combination of immunological, and specifically granulocyte-related, 446 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 31, 2021. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in respectively) approximately 4 months after hospital discharge (median=136 days, range=89-491

IgG seronegative healthy volunteers (Supplemental Table 1 ) were collected on the same days 493 as the acute COVID-19 (n=17) and convalescent (n=11) patients. All samples were processed 494 using the same standardized operating procedures. Informed consent was obtained from all 495 study participants and the study was approved by the regional Ethics Committee in Stockholm, 496

Sweden, and performed in accordance with the Declaration of Helsinki. 497 498

Absolute counts of peripheral blood leukocytes were determined for all study participants using 500 BD Trucount tubes (6-color TBNK Reagent and, in addition, CD123 BUV395 (BD 501 Biosciences), CD15 PB, CD193 BV605 and HLA-DR BV785 (Biolegend) and CD14 PE-Cy5 502 (eBioscience) according to the manufacturer's instructions. Samples were fixed in 1X BD 503 FACS lysing solution (BD Biosciences) for 2h and acquired on a BD FACSymphony A5 504 instrument, equipped with UV (355nm), violet (405 nm), blue (488 nm), yellow/green (561 505 nm) and red (637 nm) lasers. For absolute cell count calculations, the number of events for 506 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 31, 2021. ; https://doi.org/10.1101/2021.01.27.21250591 doi: medRxiv preprint populations of interest was divided by the number of bead events and multiplied by the BD 507 Trucount bead count. 508

The proximity extension assay technology (PEA), based on Q-PCR quantification of pair-wise 511 binding of oligonucleotide-labeled target antibodies (OLINK AB, Uppsala, Sweden), was used 512 for the quantification of 276 selected soluble factors in serum from the study participants 513 (Supplemental Table 4 ). 514 515

Soluble factors in the serum of the study participants were measured using 4 customized 517 multiplex panels including 36, 12, 15 and 12 analytes covering a range of human inflammatory 518 factors (R&D Systems, UK; Supplemental Table 4 ). Coagulation factors were measured in 519 plasma using 3 different multiplex panels, including the 6-, 4-, and 3-plex human ProcartaPlex 520 panels (ThermoFisher). Assays were performed according to the manufacturer's guidelines and 521 samples were acquired on a Luminex MAGPIX instrument using xPonent 4.0 software 522 (Luminex). 523 524

For flow cytometric analysis of polymorphonuclear leukocytes, EDTA whole blood samples 526 from all patients and controls were stained with fluorescently labeled antibodies (Supplemental 527 Table 7 ). In brief, plasma fractions were removed by centrifugation and cells were washed with 528 FACS buffer (PBS, 5% FCS, 0.05 mM EDTA), followed by 15-minute incubation with a 529 cocktail containing Fc-block (Miltenyi) and fluorescent-labeled antibodies for extracellular 530 staining. Dead cells were excluded using the fixable LIVE/DEAD Yellow Dead Cell Stain Kit 531 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 31, 2021. ; https://doi.org/10.1101/2021.01.27.21250591 doi: medRxiv preprint (Life Technologies). Red blood cells (RBC) were lysed with fixation/permeabilization working 532 solution (BD Cytofix/Cytoperm™). For SARS-CoV-2 inactivation, samples were fixed for two 533 additional hours in ultra-pure, methanol-free, 1% formaldehyde (Polyscience). Due to heavy 534 RBC coagulation in COVID-19 patient samples, an additional RBC lysis for 10 min was 535 performed. Samples were acquired on a BD FACSymphony equipped with five lasers (BD 536 Biosciences). 537 538 Flow cytometry data analysis 539 Standard flow cytometry data analysis was performed using FlowJo version 10. A 540 compensation matrix for the 25-color flow cytometry panel was generated using AutoSpill 541 (55), optimized and applied to all fcs files. All data was pre-processed using the time gate. 542

Following exclusion of doublets and dead cells, neutrophils were defined as CD15 + CD193 -543 CD66b + CD16 bright/dim , eosinophils were defined as CD15 bright/dim CD193 bright/dim CD16 -544 Predictive models for clinical outcomes were built based on a data set of 167 immune traits 574 that included surface marker expression levels, absolute numbers, frequencies of granulocyte 575 subsets, available clinical information and laboratory measured parameters. The creation of the 576 models was performed in R v. 3.6.0 (56). Variable redundancy was avoided by identification 577 of variables with pair-wise spearman correlation coefficient higher than 0.99 (function cor from 578 package stats), and removal of the variable with the largest mean absolute correlation. The 579 remaining variables were pair-wise correlated with the clinical outcome, and those with p-580 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 31, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 values < 0.05 were selected for further evaluation. All possible linear combinations of variables 581 were evaluated with the function regsubsets from the package leaps (68) using an 'exhaustive' 582 method and evaluating 3 subsets per model size. The models with highest adjusted R 2 , lowest 583 bayesian information criterion and a Mallow's Cp lower and closer to the number of 584 coefficients, were selected for further evaluation. The variance inflation factor for each model 585 was calculated to avoid redundancy in the independent variables with the function vir from 586 package car (69). The selected final model had no redundant variables, and all must be 587 significant (p-value < 0.05). The contribution of each parameter to each model was calculated 588 with the functions cal.relimp from package relaimpo (70) with the lgm metric. Differences in 589 the model after addition of factors for correction (sex, age, BMI, smoking, days from symptom 590 to sampling and from admission to sampling and co-morbidities) were evaluated by computing 591 an analysis of variance for the two linear models. 592 593 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 31, 2021. Curated flow cytometry data will be made available for exploration via the KI/K COVID-19 616

Immune Atlas, http://covid19cellatlas.com/. All other data needed to evaluate the conclusions 617 of the paper are presented in the paper or in the Supplemental Material. 618 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 31, 2021. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 31, 2021. and alluvial diagram (right) describing demographics and the clinical characteristics of the patients included in the study cohort. Severity groups (moderate=blue; severe=purple; deceased=gray) are indicated. (C) Gating strategy for the identification of granulocyte subsets and their UMAP projection is shown on the left. On the right, analogue results are obtained through unsupervised subset identification based on UMAP projection of total granulocytes. (D-E) Absolute cell counts (D) and frequencies (E) among total leukocytes for neutrophils, eosinophils and basophils in healthy controls (n=17), moderate COVID-19 patients (n=10) and severe COVID-19 patients (n=16). (F) Ratios of granulocyte absolute counts over lymphocyte absolute counts in healthy controls (n=17), moderate COVID-19 patients (n=10) and severe COVID-19 patients (n=16). In (D-F), Kruskall-Wallis test and two-stage Benjamini, Krieger and Yekutieli test. Bars represent median. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Neu, neutrophils; eos, eosinophils; bas, basophils; lymphs, lymphocytes. All rights reserved. No reuse allowed without permission.

perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in

The copyright holder for this this version posted January 31, 2021. ; * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 0.6 0 -0.6

Spearman correlation perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in All rights reserved. No reuse allowed without permission.

perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in

The copyright holder for this this version posted January 31, 2021. ; heathy controls, moderate and severe COVID-19 patients. (B) UMAP showing the level of expression of selected markers on basophils. (C) MFI for selected markers on basophils in heathy controls (n=17), moderate (n=10) and severe (n=12) COVID-19 patients. Median values for each group are indicated. (D) PCA and biplot based on the MFI expression of representative basophil markers in healthy controls, moderate and severe COVID-19 patients. (E) Heatmap demonstrating correlation (Spearman non-parametric, r < -0.4 or r > 0.4, p < 0.05) between absolute basophil counts/basophil frequencies of total leukocytes and basophil-associated soluble factors, in COVID-19 patients. Significant differences between healthy controls and patient groups in (C) were evaluated with Kruskall-Wallis test and two-stage Benjamini, Krieger and Yekutieli test. FDR adjusted p-values are indicated. * p < 0.05; ** p < 0.01; *** p < 0.001. All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 31, 2021. ; Moderate COVID-19 Severe COVID-19

Moderate COVID-19 Severe COVID-19

Moderate COVID-19 Severe COVID-19

All rights reserved. No reuse allowed without permission.

perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in

The copyright holder for this this version posted January 31, 2021. ; https://doi.org/10.1101/2021.01.27.21250591 doi: medRxiv preprint . Wilcoxon matched-pairs rank test; ns, not significant; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Healthy controls (n=28, median±IQR) ranges are shown in green. Bars indicate statistical significance considering all sampled patients (black), only moderate (blue) or only severe (purple) patients. Bas, Basophils; Eos, Eosinophils; Neu, Neutrophils. 

Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl 620

Characteristics of and Important Lessons From the 622

COVID-19) Outbreak in China: Summary of a

Cases From the Chinese Center for Disease Control and Prevention

COVID-19: consider cytokine storm syndromes and 625 immunosuppression

Plasma IP-10 and MCP-3 levels are highly associated with disease 627 severity and predict the progression of COVID-19

Imbalanced Host Response to SARS-CoV-2 Drives Development 630 of COVID-19

Longitudinal analyses reveal immunological misfiring in severe COVID-632 19

Neutrophils in the activation and regulation of innate and adaptive 634 immunity

Longitudinal characteristics of lymphocyte responses and cytokine profiles 636 in the peripheral blood of SARS-CoV-2 infected patients

Sex-Based Differences in Susceptibility to Severe Acute 639

Respiratory Syndrome Coronavirus Infection

Clinical predictors of mortality of Middle East Respiratory Syndrome 641

MERS-CoV) infection: A cohort study

Human versus mouse eosinophils: "that which we call an eosinophil, by 644 any other name would stain as red

A Role for Neutrophils in Viral Respiratory Disease

Host-pathogen interactions during coronavirus infection of 648 primary alveolar epithelial cells

Multifaceted roles of basophils in health and disease

Eosinophils and their interactions with respiratory virus pathogens

Single-cell landscape of bronchoalveolar immune cells in patients with 654 COVID-19

COVID-19 severity correlates with airway epithelium-immune cell 656 interactions identified by single-cell analysis

A single-cell atlas of the peripheral immune response in patients with 658 severe COVID-19

Severe COVID-19 Is Marked by a Dysregulated Myeloid 660

Expansion of myeloid-derived suppressor cells in patients with severe 662 coronavirus disease (COVID-19)

Impaired type I interferon activity and inflammatory responses in severe 664 COVID-19 patients

Neutrophil Diversity in Health and Disease

The clinical significance of myeloid-derived suppressor cells in dengue 692 fever patients

Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate 694

Severe from Mild COVID-19

Immune suppression by neutrophils in HIV-1 infection: role of PD-696

L1/PD-1 pathway

Whole blood immunophenotyping uncovers immature neutrophil-698 to-VD2 T-cell ratio as an early marker for severe COVID-19

Neutrophils responsive to endogenous IFN-beta regulate tumor 701 angiogenesis and growth in a mouse tumor model

Transcriptomic, epigenetic, and functional analyses implicate neutrophil 704 diversity in the pathogenesis of systemic lupus erythematosus

Single-cell transcriptome profiling reveals neutrophil heterogeneity in 707 homeostasis and infection

Neutrophils-related host factors associated with severe disease and 709 fatality in patients with influenza infection

Inhibition of influenza virus replication by nitric oxide

Lung-resident eosinophils represent a distinct regulatory eosinophil 713 subset

Eosinophils and Respiratory Viruses

Human and Mouse Eosinophils Have Antiviral Activity against 717

Eosinophil responses during COVID-19 infections and coronavirus 719 vaccination

Human Blood-Circulating Basophils Capture HIV-1 and Mediate Viral 721 trans-Infection of CD4+ T Cells

HIV-1 Nef promotes migration and chemokine synthesis of human 723 basophils and mast cells through the interaction with CXCR4

Adhesion molecule cross-linking and cytokine exposure modulate IgE-726 and non-IgE-dependent basophil activation

Eosinophils: changing perspectives in health and disease

Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 730 patients in fever clinic: A retrospective case-control study

A dynamic COVID-19 immune signature includes associations with 733 poor prognosis

Immunology of COVID-19: Current State of the Science

AutoSpill: a method for calculating spillover coefficients in high-737 parameter flow cytometry

Extract and Visualize the Results of 740

Multivariate Data Analyses

FactoMineR: An R Package for Multivariate Analysis

Software

Econometric Tools for Performance and 744

Risk Analysis

Elegant Graphics for Data Analysis

gplots: Various R Programming Tools for Plotting Data

pheatmap: Pretty Heatmaps

Community Ecology Package. 2020

Visualization of a Correlation Matrix

Lattice: Multivariate Data Visualization with R. Use R!

Extra Graphical Utilities Based on Lattice

Complex heatmaps reveal patterns and correlations in multidimensional 754 genomic data

leaps: Regression Subset Selection. Based on Fortran code by Alan Miller

car: Companion to Applied Regression

Relative Importance of Regressors in Linear 759

Severe COVID-19 Deceased ** **